
Cost-Effectiveness of Interventions Related to the Treatment of Women With Polycystic Ovary Syndrome: A Scoping Review
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of reproductive-aged women.1 The global prevalence of PCOS among this cohort is 4–20%.2 Variability in the global prevalence is largely explained by differences in …